Effect of sodium valproate and docosahexaenoic acid on inflammation in rats

Sushil Kiran Kunder, K. L. Bairy, A. Avinash

Research output: Contribution to journalArticle

Abstract

Objective: To evaluate the anti-inflammatory activity of sodium valproate and docosahexaenoic acid (DHA) supplementation using various experimental models in albino Wistar rats. Method: A total of 48 adult Wistar albino male rats were divided into 8 groups of 6 rats each. Group I was control (distilled water 1 ml/kg), Group II received intraperitoneal (i.p.) injection of indomethacin (10 mg/kg), Groups III-V were injected (i.p.) with sodium valproate 100, 200, and 400 mg/kg water, and Groups VI-VIII were given sodium valproate 100, 200, and 400 mg/kg plus DHA 300 mg/kg (i.p.), respectively. Anti-inflammatory activity was assessed using carrageenan induced paw edema and the cotton pellet granuloma models. Results: We found that higher doses of sodium valproate (400 mg/kg) used either alone or with a combination of DHA (300 mg/kg) showed a significant anti-inflammatory activity when compared to control in both the models of inflammation. Conclusion: Combination of sodium valproate along DHA has shown promising anti-inflammatory activity.

Original languageEnglish
Pages (from-to)286-289
Number of pages4
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume10
Issue number1
DOIs
Publication statusPublished - 01-01-2017
Externally publishedYes

Fingerprint

Docosahexaenoic Acids
Valproic Acid
Inflammation
Anti-Inflammatory Agents
Water
Carrageenan
Granuloma
Intraperitoneal Injections
Indomethacin
Wistar Rats
Edema
Theoretical Models

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

Kunder, Sushil Kiran ; Bairy, K. L. ; Avinash, A. / Effect of sodium valproate and docosahexaenoic acid on inflammation in rats. In: Asian Journal of Pharmaceutical and Clinical Research. 2017 ; Vol. 10, No. 1. pp. 286-289.
@article{c92d055a706b49f4b1ff1f610edd31fd,
title = "Effect of sodium valproate and docosahexaenoic acid on inflammation in rats",
abstract = "Objective: To evaluate the anti-inflammatory activity of sodium valproate and docosahexaenoic acid (DHA) supplementation using various experimental models in albino Wistar rats. Method: A total of 48 adult Wistar albino male rats were divided into 8 groups of 6 rats each. Group I was control (distilled water 1 ml/kg), Group II received intraperitoneal (i.p.) injection of indomethacin (10 mg/kg), Groups III-V were injected (i.p.) with sodium valproate 100, 200, and 400 mg/kg water, and Groups VI-VIII were given sodium valproate 100, 200, and 400 mg/kg plus DHA 300 mg/kg (i.p.), respectively. Anti-inflammatory activity was assessed using carrageenan induced paw edema and the cotton pellet granuloma models. Results: We found that higher doses of sodium valproate (400 mg/kg) used either alone or with a combination of DHA (300 mg/kg) showed a significant anti-inflammatory activity when compared to control in both the models of inflammation. Conclusion: Combination of sodium valproate along DHA has shown promising anti-inflammatory activity.",
author = "Kunder, {Sushil Kiran} and Bairy, {K. L.} and A. Avinash",
year = "2017",
month = "1",
day = "1",
doi = "10.22159/ajpcr.2017.v10i1.15207",
language = "English",
volume = "10",
pages = "286--289",
journal = "Asian Journal of Pharmaceutical and Clinical Research",
issn = "0974-2441",
publisher = "Innovare Academics Sciences Pvt. Ltd",
number = "1",

}

Effect of sodium valproate and docosahexaenoic acid on inflammation in rats. / Kunder, Sushil Kiran; Bairy, K. L.; Avinash, A.

In: Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, No. 1, 01.01.2017, p. 286-289.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of sodium valproate and docosahexaenoic acid on inflammation in rats

AU - Kunder, Sushil Kiran

AU - Bairy, K. L.

AU - Avinash, A.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective: To evaluate the anti-inflammatory activity of sodium valproate and docosahexaenoic acid (DHA) supplementation using various experimental models in albino Wistar rats. Method: A total of 48 adult Wistar albino male rats were divided into 8 groups of 6 rats each. Group I was control (distilled water 1 ml/kg), Group II received intraperitoneal (i.p.) injection of indomethacin (10 mg/kg), Groups III-V were injected (i.p.) with sodium valproate 100, 200, and 400 mg/kg water, and Groups VI-VIII were given sodium valproate 100, 200, and 400 mg/kg plus DHA 300 mg/kg (i.p.), respectively. Anti-inflammatory activity was assessed using carrageenan induced paw edema and the cotton pellet granuloma models. Results: We found that higher doses of sodium valproate (400 mg/kg) used either alone or with a combination of DHA (300 mg/kg) showed a significant anti-inflammatory activity when compared to control in both the models of inflammation. Conclusion: Combination of sodium valproate along DHA has shown promising anti-inflammatory activity.

AB - Objective: To evaluate the anti-inflammatory activity of sodium valproate and docosahexaenoic acid (DHA) supplementation using various experimental models in albino Wistar rats. Method: A total of 48 adult Wistar albino male rats were divided into 8 groups of 6 rats each. Group I was control (distilled water 1 ml/kg), Group II received intraperitoneal (i.p.) injection of indomethacin (10 mg/kg), Groups III-V were injected (i.p.) with sodium valproate 100, 200, and 400 mg/kg water, and Groups VI-VIII were given sodium valproate 100, 200, and 400 mg/kg plus DHA 300 mg/kg (i.p.), respectively. Anti-inflammatory activity was assessed using carrageenan induced paw edema and the cotton pellet granuloma models. Results: We found that higher doses of sodium valproate (400 mg/kg) used either alone or with a combination of DHA (300 mg/kg) showed a significant anti-inflammatory activity when compared to control in both the models of inflammation. Conclusion: Combination of sodium valproate along DHA has shown promising anti-inflammatory activity.

UR - http://www.scopus.com/inward/record.url?scp=85010403045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010403045&partnerID=8YFLogxK

U2 - 10.22159/ajpcr.2017.v10i1.15207

DO - 10.22159/ajpcr.2017.v10i1.15207

M3 - Article

AN - SCOPUS:85010403045

VL - 10

SP - 286

EP - 289

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 1

ER -